Suppr超能文献

通过房水游离DNA诊断出的伴有MYCN扩增的视网膜母细胞瘤。

Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor.

作者信息

Joseph Sarah, Pike Sarah, Peng Chen-Ching, Brown Brianne, Xu Liya, Berry Jesse L, Chévez-Barrios Patricia, Hubbard G Baker, Grossniklaus Hans E

机构信息

Department of Ophthalmology, Emory University School of Medicine, Los Angeles, CA, USA.

Children's Hospital Los Angeles and the USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

出版信息

Ocul Oncol Pathol. 2024 Apr;10(1):15-24. doi: 10.1159/000533311. Epub 2023 Aug 25.

Abstract

INTRODUCTION

The objective of this study was to report the clinicopathologic features of three cases of -amplified retinoblastoma identified genetically by aqueous humor sampling.

METHODS

Whole-genome sequencing was performed using isolated cell-free DNA (cfDNA) from aqueous humor of 3 retinoblastoma patients. We analyzed genomic copy number and mutational alterations, histologic and pathologic features, and clinical data.

RESULTS

The most common genetic alteration identified in these three retinoblastoma cases was a focal amplification on 2p. All tumors showed an early age of diagnosis with a median of 9 months. The tumor histopathologic features included neovascularization and subretinal seeding in case 1, diffuse nature with choroidal and prelaminar optic nerve invasion in case 2, and complete vitreous seeding in case 3. Case 1 expressed RB protein and had no mutation, case 2 did not express RB protein and had an mutation, and case 3 did not express RB protein and likely had an epigenetic effect on RB expression.

CONCLUSIONS

Our report shows 3 cases of unilateral retinoblastomas diagnosed in patients ranging from 4 months to 18 months old. Genomic analysis from AH cfDNA revealed amplification with intact RB protein staining in case 1 and lack of RB staining in cases 2 and 3. mutational analysis in the AH confirmed a pathogenic variant in case 2. Clinical pathology showed features requiring aggressive treatment, specifically enucleation.

IMPORTANCE

-amplified retinoblastomas demonstrate unique pathogenesis and aggressive behavior, regardless if is a primary or secondary driver of disease. Genomic analysis from aqueous humor may be useful when deciding to enucleate as opposed to treating conservatively. Focal amplification on 2p might be relevant for tumor growth in this subset of the retinoblastoma population in terms of targeted therapeutics.

摘要

引言

本研究的目的是报告通过房水采样基因鉴定出的三例MYCN扩增的视网膜母细胞瘤的临床病理特征。

方法

对3例视网膜母细胞瘤患者房水中分离出的游离细胞DNA(cfDNA)进行全基因组测序。我们分析了基因组拷贝数和突变改变、组织学和病理学特征以及临床数据。

结果

在这三例视网膜母细胞瘤病例中鉴定出的最常见基因改变是2p上的局灶性MYCN扩增。所有肿瘤诊断时年龄均较小,中位年龄为9个月。肿瘤组织病理学特征包括病例1中的新生血管形成和视网膜下播散,病例2中的弥漫性特征伴脉络膜和视神经板前浸润,病例3中的完全玻璃体播散。病例1表达RB蛋白且无MYCN突变,病例2不表达RB蛋白且有MYCN突变,病例3不表达RB蛋白且可能对RB表达有表观遗传效应。

结论

我们的报告显示3例单侧视网膜母细胞瘤,患者年龄在4个月至18个月之间。房水cfDNA的基因组分析显示病例1中MYCN扩增且RB蛋白染色完整,病例2和3中缺乏RB染色。房水中的MYCN突变分析证实病例2存在致病变异。临床病理学显示需要积极治疗的特征,特别是眼球摘除术。

重要性

MYCN扩增的视网膜母细胞瘤表现出独特的发病机制和侵袭性,无论MYCN是疾病的主要还是次要驱动因素。与保守治疗相比,房水的基因组分析在决定是否进行眼球摘除术时可能有用。2p上的局灶性MYCN扩增在视网膜母细胞瘤人群的这一亚组中对于肿瘤生长可能与靶向治疗相关。

相似文献

1
Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor.
Ocul Oncol Pathol. 2024 Apr;10(1):15-24. doi: 10.1159/000533311. Epub 2023 Aug 25.
2
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
3
Single-cell somatic copy number alteration profiling of vitreous humor seeds in retinoblastoma.
Ophthalmic Genet. 2024 Dec;45(6):646-649. doi: 10.1080/13816810.2024.2374886. Epub 2024 Jul 17.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.
Cochrane Database Syst Rev. 2017 Feb 22;2(2):CD012131. doi: 10.1002/14651858.CD012131.pub2.

引用本文的文献

4
Retinoblastoma: Aqueous humor liquid biopsy.
Taiwan J Ophthalmol. 2025 Mar 20;15(1):55-61. doi: 10.4103/tjo.TJO-D-24-00133. eCollection 2025 Jan-Mar.

本文引用的文献

1
MRI Features for Identifying -amplified Wild-type Retinoblastoma.
Radiology. 2023 Jun;307(5):e222264. doi: 10.1148/radiol.222264. Epub 2023 May 16.
2
Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy.
Nat Commun. 2022 Sep 21;13(1):5523. doi: 10.1038/s41467-022-33248-2.
3
Circulating DNA and Liquid Biopsies in the Management of Patients with Cancer.
Cancer Res. 2022 Jun 15;82(12):2213-2215. doi: 10.1158/0008-5472.CAN-22-1405.
4
Retinoblastoma outcomes: a global perspective.
Lancet Glob Health. 2022 Mar;10(3):e307-e308. doi: 10.1016/S2214-109X(21)00598-2. Epub 2022 Jan 27.
5
Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers.
J Mol Diagn. 2021 Dec;23(12):1714-1721. doi: 10.1016/j.jmoldx.2021.08.014. Epub 2021 Oct 15.
7
Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma.
Cancers (Basel). 2021 Jul 3;13(13):3340. doi: 10.3390/cancers13133340.
9
Simultaneous identification of clinically relevant mutations and copy number alterations in aqueous humor of retinoblastoma eyes.
Ophthalmic Genet. 2020 Dec;41(6):526-532. doi: 10.1080/13816810.2020.1799417. Epub 2020 Aug 17.
10
FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma.
Oncogene. 2019 Oct;38(41):6737-6751. doi: 10.1038/s41388-019-0912-5. Epub 2019 Aug 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验